Craig Chambliss Spent 30 Years Learning How a Drug Becomes a Company

Before Neurelis had a commercial product, Craig Chambliss had already learned the industry from the sales call to the acquisition table. His career is a study in patient capital, practical company-building and the unglamorous middle where science becomes infrastructure.